Document is current
Any future updates will be listed below
-
Authors
Nakagawa, Ryoko
Nani, Francesca https://orcid.org/0009-0002-5955-7244
Hipp, Joerg F. https://orcid.org/0000-0002-7875-2988
Honer, Michael https://orcid.org/0000-0003-4818-9984
Knoflach, Frederic
Gasser, Rodolfo
Ozmen, Laurence
Tamada, Kota
Fjeldskaar, Fatiha
Takacs, Livia
Vautheny, Audrey
Morairty, Stephen R. https://orcid.org/0000-0002-0781-1645
Saxe, Michael
Takumi, Toru https://orcid.org/0000-0001-7153-266X
Hernandez, Maria-Clemencia https://orcid.org/0000-0003-1621-4188
-
Funding
Funding for this research was provided by:
Roche
- License Information
-
More Information
Article History
Received: 30 October 2024
Revised: 29 July 2025
Accepted: 5 September 2025
First Online: 5 January 2026
Ethics approval
: All experimental procedures were approved and performed in accordance with the City of Basel Cantonal Animal Protection Committee (AUP #2359) based on adherence to federal and local regulations on animal maintenance and testing.
: This study was funded by F. Hoffmann-La Roche Ltd. At the time of the study, Ryoko Nakagawa, Francesca Nani, Joerg Hipp, Michael Honer, Frederic Knoflach, Rodolfo Gasser, Laurence Ozmen, Fatiha Fjeldskaar, Livia Takacs, Audrey Vautheny, Michael Saxe, Maria-Clemencia Hernandez were employees of F. Hoffmann-La Roche Ltd. Switzerland. All employees (former and current) may be eligible for stock and stock options. Kota Tamada, Toru Takumi and Stephen R. Morairty have no competing interests.
